Merck & Co Inc at TD Cowen Healthcare Conference Transcript
(technical difficulty) sixth annual health care conference. We are absolutely delighted to have Merck senior leadership here with us today. Representing the company, Caroline Litchfield, who is Executive Vice President and Chief Financial Officer; and Dr. Dean Li, who is President of Merck Research Labs, lots to talk about, both in the pipeline as well as the current operations. But to set the stage, Caroline, I'll turn it to you.
Thank you, Steve. So good afternoon, all. Thank you for being here and thank you for your support and interest in Merck. Our company is transforming its portfolio. We're launching many new products including WINREVAIR, OHTUVAYRE, CAPVAXIVE Enflonsia, and QLEX. We're in the midst of having more than 20 new growth drivers in our Human Health business.
Every one of these products has the promise of advancing patient care and almost every product has blockbuster potential. And we've highlighted that there's
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
